Cargando…
Chyme Reinfusion Restores the Regulatory Bile Salt–FGF19 Axis in Patients With Intestinal Failure
BACKGROUND AND AIMS: Automated chyme reinfusion (CR) in patients with intestinal failure (IF) and a temporary double enterostomy (TDE) restores intestinal function and protects against liver injury, but the mechanisms are incompletely understood. The aim was to investigate whether the beneficial eff...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596508/ https://www.ncbi.nlm.nih.gov/pubmed/34133768 http://dx.doi.org/10.1002/hep.32017 |
_version_ | 1784600393126248448 |
---|---|
author | Koelfat, Kiran V.K. Picot, Denis Chang, Xinwei Desille‐Dugast, Mireille van Eijk, Hans M. van Kuijk, Sander M.J. Lenicek, Martin Layec, Sabrina Carsin, Marie Dussaulx, Laurence Seynhaeve, Eloi Trivin, Florence Lacaze, Laurence Thibault, Ronan Schaap, Frank G. Olde Damink, Steven W.M. |
author_facet | Koelfat, Kiran V.K. Picot, Denis Chang, Xinwei Desille‐Dugast, Mireille van Eijk, Hans M. van Kuijk, Sander M.J. Lenicek, Martin Layec, Sabrina Carsin, Marie Dussaulx, Laurence Seynhaeve, Eloi Trivin, Florence Lacaze, Laurence Thibault, Ronan Schaap, Frank G. Olde Damink, Steven W.M. |
author_sort | Koelfat, Kiran V.K. |
collection | PubMed |
description | BACKGROUND AND AIMS: Automated chyme reinfusion (CR) in patients with intestinal failure (IF) and a temporary double enterostomy (TDE) restores intestinal function and protects against liver injury, but the mechanisms are incompletely understood. The aim was to investigate whether the beneficial effects of CR relate to functional recovery of enterohepatic signaling through the bile salt–FGF19 axis. APPROACH AND RESULTS: Blood samples were collected from 12 patients, 3 days before, at start, and 1, 3, 5, and 7 weeks after CR initiation. Plasma FGF19, total bile salts (TBS), 7‐α‐hydroxy‐4‐cholesten‐3‐one (C4; a marker of bile salt synthesis), citrulline (CIT), bile salt composition, liver tests, and nutritional risk indices were determined. Paired small bowel biopsies prior to CR and after 21 days were taken, and genes related to bile salt homeostasis and enterocyte function were assessed. CR induced an increase in plasma FGF19 and decreased C4 levels, indicating restored regulation of bile salt synthesis through endocrine FGF19 action. TBS remained unaltered during CR. Intestinal farnesoid X receptor was up‐regulated after 21 days of CR. Secondary and deconjugated bile salt fractions were increased after CR, reflecting restored microbial metabolism of host bile salts. Furthermore, CIT and albumin levels gradually rose after CR, while abnormal serum liver tests normalized after CR, indicating restored intestinal function, improved nutritional status, and amelioration of liver injury. CR increased gene transcripts related to enterocyte number, carbohydrate handling, and bile salt homeostasis. Finally, the reciprocal FGF19/C4 response after 7 days predicted the plasma CIT time course. CONCLUSIONS: CR in patients with IF‐TDE restored bile salt–FGF19 signaling and improved gut–liver function. Beneficial effects of CR are partly mediated by recovery of the bile salt–FGF19 axis and subsequent homeostatic regulation of bile salt synthesis. |
format | Online Article Text |
id | pubmed-8596508 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85965082021-11-22 Chyme Reinfusion Restores the Regulatory Bile Salt–FGF19 Axis in Patients With Intestinal Failure Koelfat, Kiran V.K. Picot, Denis Chang, Xinwei Desille‐Dugast, Mireille van Eijk, Hans M. van Kuijk, Sander M.J. Lenicek, Martin Layec, Sabrina Carsin, Marie Dussaulx, Laurence Seynhaeve, Eloi Trivin, Florence Lacaze, Laurence Thibault, Ronan Schaap, Frank G. Olde Damink, Steven W.M. Hepatology Original Articles BACKGROUND AND AIMS: Automated chyme reinfusion (CR) in patients with intestinal failure (IF) and a temporary double enterostomy (TDE) restores intestinal function and protects against liver injury, but the mechanisms are incompletely understood. The aim was to investigate whether the beneficial effects of CR relate to functional recovery of enterohepatic signaling through the bile salt–FGF19 axis. APPROACH AND RESULTS: Blood samples were collected from 12 patients, 3 days before, at start, and 1, 3, 5, and 7 weeks after CR initiation. Plasma FGF19, total bile salts (TBS), 7‐α‐hydroxy‐4‐cholesten‐3‐one (C4; a marker of bile salt synthesis), citrulline (CIT), bile salt composition, liver tests, and nutritional risk indices were determined. Paired small bowel biopsies prior to CR and after 21 days were taken, and genes related to bile salt homeostasis and enterocyte function were assessed. CR induced an increase in plasma FGF19 and decreased C4 levels, indicating restored regulation of bile salt synthesis through endocrine FGF19 action. TBS remained unaltered during CR. Intestinal farnesoid X receptor was up‐regulated after 21 days of CR. Secondary and deconjugated bile salt fractions were increased after CR, reflecting restored microbial metabolism of host bile salts. Furthermore, CIT and albumin levels gradually rose after CR, while abnormal serum liver tests normalized after CR, indicating restored intestinal function, improved nutritional status, and amelioration of liver injury. CR increased gene transcripts related to enterocyte number, carbohydrate handling, and bile salt homeostasis. Finally, the reciprocal FGF19/C4 response after 7 days predicted the plasma CIT time course. CONCLUSIONS: CR in patients with IF‐TDE restored bile salt–FGF19 signaling and improved gut–liver function. Beneficial effects of CR are partly mediated by recovery of the bile salt–FGF19 axis and subsequent homeostatic regulation of bile salt synthesis. John Wiley and Sons Inc. 2021-08-26 2021-11 /pmc/articles/PMC8596508/ /pubmed/34133768 http://dx.doi.org/10.1002/hep.32017 Text en © 2021 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Koelfat, Kiran V.K. Picot, Denis Chang, Xinwei Desille‐Dugast, Mireille van Eijk, Hans M. van Kuijk, Sander M.J. Lenicek, Martin Layec, Sabrina Carsin, Marie Dussaulx, Laurence Seynhaeve, Eloi Trivin, Florence Lacaze, Laurence Thibault, Ronan Schaap, Frank G. Olde Damink, Steven W.M. Chyme Reinfusion Restores the Regulatory Bile Salt–FGF19 Axis in Patients With Intestinal Failure |
title | Chyme Reinfusion Restores the Regulatory Bile Salt–FGF19 Axis in Patients With Intestinal Failure |
title_full | Chyme Reinfusion Restores the Regulatory Bile Salt–FGF19 Axis in Patients With Intestinal Failure |
title_fullStr | Chyme Reinfusion Restores the Regulatory Bile Salt–FGF19 Axis in Patients With Intestinal Failure |
title_full_unstemmed | Chyme Reinfusion Restores the Regulatory Bile Salt–FGF19 Axis in Patients With Intestinal Failure |
title_short | Chyme Reinfusion Restores the Regulatory Bile Salt–FGF19 Axis in Patients With Intestinal Failure |
title_sort | chyme reinfusion restores the regulatory bile salt–fgf19 axis in patients with intestinal failure |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596508/ https://www.ncbi.nlm.nih.gov/pubmed/34133768 http://dx.doi.org/10.1002/hep.32017 |
work_keys_str_mv | AT koelfatkiranvk chymereinfusionrestorestheregulatorybilesaltfgf19axisinpatientswithintestinalfailure AT picotdenis chymereinfusionrestorestheregulatorybilesaltfgf19axisinpatientswithintestinalfailure AT changxinwei chymereinfusionrestorestheregulatorybilesaltfgf19axisinpatientswithintestinalfailure AT desilledugastmireille chymereinfusionrestorestheregulatorybilesaltfgf19axisinpatientswithintestinalfailure AT vaneijkhansm chymereinfusionrestorestheregulatorybilesaltfgf19axisinpatientswithintestinalfailure AT vankuijksandermj chymereinfusionrestorestheregulatorybilesaltfgf19axisinpatientswithintestinalfailure AT lenicekmartin chymereinfusionrestorestheregulatorybilesaltfgf19axisinpatientswithintestinalfailure AT layecsabrina chymereinfusionrestorestheregulatorybilesaltfgf19axisinpatientswithintestinalfailure AT carsinmarie chymereinfusionrestorestheregulatorybilesaltfgf19axisinpatientswithintestinalfailure AT dussaulxlaurence chymereinfusionrestorestheregulatorybilesaltfgf19axisinpatientswithintestinalfailure AT seynhaeveeloi chymereinfusionrestorestheregulatorybilesaltfgf19axisinpatientswithintestinalfailure AT trivinflorence chymereinfusionrestorestheregulatorybilesaltfgf19axisinpatientswithintestinalfailure AT lacazelaurence chymereinfusionrestorestheregulatorybilesaltfgf19axisinpatientswithintestinalfailure AT thibaultronan chymereinfusionrestorestheregulatorybilesaltfgf19axisinpatientswithintestinalfailure AT schaapfrankg chymereinfusionrestorestheregulatorybilesaltfgf19axisinpatientswithintestinalfailure AT oldedaminkstevenwm chymereinfusionrestorestheregulatorybilesaltfgf19axisinpatientswithintestinalfailure |